Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Journal of Cardiovascular Pharmacology and Therapeutics|July 1, 2020
Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World SettingEnrico Melillo, Anna Rago, Riccardo Proietti, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 31, 2024
Predicting worsening heart failure hospitalizations in patients with implantable cardioverter defibrillators: is it all about alerts? A pooled analysis of nine trialsGiovanni Luca Botto, Gianfranco Sinagra, Alan Bulava, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|March 25, 2020
Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate doseVincenzo Russo, Anna Rago, Nunzia Laezza, et al.
International Journal of Molecular Sciences|November 12, 2016
Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited CardiomyopathiesGiulia Frisso, Nicola Detta, Pamela Coppola, et al.
Heart Rhythm|September 28, 2023
Basic science of cardiac contractility modulation therapy: Molecular and electrophysiological mechanismsDaniele Masarone, Michelle M Kittleson, Antonio D'Onofrio, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 12, 2021
Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD "Monaldi care" registryBerardo Sarubbi, Diego Colonna, Anna Correra, et al.
Journal of Blood Medicine|March 19, 2020
Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug EvaluationVincenzo Russo, Andrea Paccone, Anna Rago, et al.
Minerva Cardioangiologica|September 27, 2017
Budget impact analysis of rivaroxaban vs. warfarin anticoagulation strategy for direct current cardioversion in non-valvular atrial fibrillation patients: the MonaldiVert Economic StudyVincenzo Russo, Anna Rago, Andrea A Papa, et al.
Expert Review of Medical Devices|October 22, 2020
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdownVincenzo Russo, Pia Clara Pafundi, Antonio Rapacciuolo, et al.
Therapeutic Advances in Drug Safety|March 4, 2017
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidenceVincenzo Russo, Anna Rago, Riccardo Proietti, et al.
Pageof 18